specialist
advisori
committe
antimicrobi
resist
sacar
set
follow
public
stand
medic
advisori
committe
invit
join
mainli
experi
diseas
surveil
commun
committe
approach
end
life
time
reflect
recent
develop
particularli
issu
concern
gener
practic
paper
circul
prior
initi
meet
committe
contain
two
surpris
firstli
uk
antibiot
given
anim
human
subsequ
report
health
protect
agenc
one
factor
influenc
develop
antibiot
resist
sinc
substanti
reduct
livestock
food
anim
total
quantiti
antibiot
given
chang
wherea
import
meat
meat
product
increas
like
contain
less
antibiot
thu
risk
associ
introduct
food
chain
increas
secondli
balanc
evid
belief
inappropri
prescrib
gener
practic
influenc
develop
antibiot
resist
inconclus
minor
public
fail
reach
definit
conclus
associ
difficulti
interpret
lie
wide
variat
patient
investig
laboratori
practic
within
initi
govern
respons
three
key
element
strategi
identifi
name
surveil
prudent
antimicrobi
use
infect
carri
resourc
implic
sacar
perspect
seem
result
competit
fund
rather
develop
integr
packag
consist
record
essenti
order
monitor
trend
recogn
chang
current
systemat
approach
data
entri
gener
practic
record
standard
laboratori
comput
technolog
wherebi
practicebas
patient
record
updat
link
diagnost
prescrib
laboratori
data
one
episod
ill
extens
use
free
text
especi
relat
record
inform
minor
ill
milit
autom
investig
patient
record
qualiti
outcom
framework
could
perhap
exploit
achiev
highqual
standard
record
ensur
import
inform
enter
access
code
form
hidden
free
text
essenti
report
inform
diseas
prescript
miss
link
chang
time
clearli
expos
ensur
valid
interpret
analysi
trend
particular
care
need
interpret
base
chang
proport
rate
base
anyth
agespecif
popul
ethic
deliv
healthcar
focus
benefit
individu
public
health
less
import
mani
right
individu
champion
expens
right
societi
gener
person
use
facil
nh
inform
obtain
avail
manag
maxim
commun
health
individu
confidenti
paramount
surveil
purpos
patientspecif
inform
link
point
echo
govern
patient
identif
surveil
greatli
hinder
recent
propos
allow
person
opt
nation
record
system
either
total
partial
potenti
fulli
computer
record
diseas
surveil
never
fulli
realiz
critic
inform
withheld
exampl
part
routin
manag
drugresist
influenza
viru
isol
interpret
signific
requir
inform
individu
regard
comorbid
drug
exposur
record
inaccess
inadequ
purpos
inform
highli
import
public
health
lost
surveil
differ
research
requir
ethic
advanc
develop
nearpati
test
potenti
mix
bless
posit
side
accur
diagnosi
desir
individu
patient
manag
surveil
identif
pathogen
suffici
indic
antibiot
prescript
test
increas
consult
time
carri
signific
cost
often
disproportion
therapeut
benefit
nevertheless
potenti
valu
use
dedic
surveil
scheme
explor
sacar
discourag
extens
antibiot
prescrib
nurs
practition
move
permit
overthecount
use
recommend
endors
initi
govern
respons
select
extens
made
lifetim
committe
basi
believ
develop
antibiot
resist
acceler
whether
extens
describ
prudent
debat
recent
public
antimicrobi
resist
prefac
head
window
opportun
close
lack
new
antibiot
high
cost
develop
like
limit
market
may
serious
limit
option
control
infect
within
forese
sacar
given
way
new
committe
remit
combin
issu
antibiot
resist
control
infect
hospit
equal
import
problem
view
merger
concern
fundament
need
reduc
inappropri
antibiot
prescrib
take
place
gener
practic
larger
combin
committe
like
margin
issu
reliabl
data
primari
care
put
back
still
introduct
scientif
base
surveil
programm
prescrib
ration
threat
pandem
influenza
domin
strateg
health
plan
threat
must
underestim
equal
vigour
need
context
emerg
antibiot
resist
wonder
along
other
yet
address
need
adequ
long
scientif
basi
first
measur
tackl
none
declar
